Lab
Laboratorio Clinico Otoao LLC
Laboratorio Clinico Otoao LLC was paid $677K by Medicaid between Mar 2021 and Oct 2024, across 42 billing codes. Its largest line is 87426, Infectious agent antigen detection, SARS-CoV-2 (COVID-19) — 30% of everything it billed.
33Billing provider infoLABORATORIO CLINICO OTOAO LLC
UTUADO, PR 00641
UTUADO, PR 00641
33aNPI1104430883assigned 09/01/2020
33bProvider typeClinical Medical Laboratory
28Total paid$677K
24GClaims45,699
24DCodes billed42
24AFirst – last monthMar 2021 – Oct 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#192 of 777
Median peer was paid$278K
This provider vs. median2.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 11,002 | $216K | |
| 2022 | 8,472 | $174K | |
| 2023 | 11,372 | $110K | |
| 2024incomplete | 14,853 | $177K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 30% | 5,203 | 4,626 | $205K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 17% | 4,778 | 4,199 | $112K |
| 84443 | Thyroid stimulating hormone (TSH) | 7.7% | 3,581 | 3,311 | $52K |
| 80061 | Lipid panel | 5.8% | 3,404 | 3,150 | $40K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.9% | 5,054 | 4,542 | $33K |
| 80053 | Comprehensive metabolic panel | 4.9% | 3,628 | 3,317 | $33K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 4.9% | 1,266 | 1,179 | $33K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 4.0% | 552 | 511 | $27K |
| 83036 | Hemoglobin; glycosylated (A1C) | 2.6% | 2,141 | 1,992 | $18K |
| 82274 | 2.1% | 1,019 | 958 | $14K | |
| 86738 | 1.8% | 991 | 910 | $12K | |
| 87276 | 1.7% | 985 | 938 | $12K |
30 more codes
| 81000 | 1.7% | 4,146 | $11K | |
| 87275 | 1.7% | 981 | $11K | |
| 80074 | 1.2% | 194 | $8K | |
| 82607 | 1.2% | 603 | $8K | |
| 82043 | 1.2% | 1,460 | $8K | |
| 84153 | <1% | 358 | $6K | |
| 86701 | <1% | 628 | $5K | |
| 85027 | <1% | 752 | $5K | |
| 84439 | <1% | 457 | $4K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 511 | $4K |
| 87088 | <1% | 412 | $3K | |
| 82570 | <1% | 509 | $2K | |
| 84436 | <1% | 309 | $2K | |
| 84479 | <1% | 317 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 227 | $1K |
| 84480 | <1% | 91 | $1K | |
| 86328 | <1% | 54 | $1K | |
| 82947 | <1% | 252 | $784.67 | |
| 85651 | <1% | 240 | $757.07 | |
| 85730 | <1% | 101 | $575.29 | |
| 86592 | <1% | 152 | $557.96 | |
| 85610 | <1% | 102 | $379.98 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 45 | $314.10 |
| 81001 | <1% | 73 | $252.58 | |
| 83525 | <1% | 24 | $242.84 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 42 | $149.17 |
| 86803 | <1% | 12 | $126.32 | |
| 86140 | <1% | 21 | $76.90 | |
| 82565 | <1% | 12 | $54.45 | |
| 84520 | <1% | 12 | $41.98 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialNIEVES, JOHANNA (OWNER)